Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin N-of-1 trial for insomnia in Parkinson's disease
ACTRN12617001103358Phase 4Not yet recruiting
- Sponsor
- The University of Queensland
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of melatonin in Insomnia and Parkinson's disease (PD) (2 arms), sponsored by The University of Queensland. Primary endpoint: Sleep quality measured by Parkinson's Disease Sleep Scale-2. Planned start Aug 2018; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
InsomniaParkinson's disease (PD)
Beyond the preview
Go deeper on ACTRN12617001103358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001103358.